Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:05 AM
Study NCT ID:
NCT00310518
Status:
COMPLETED
Last Update Posted:
2009-04-29
First Post:
2006-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
Sponsor:
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2007-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-31
First Submit QC Date:
None
Study First Post Date:
2006-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-04-28
Last Update Post Date:
2009-04-29
Last Update Post Date Type:
ESTIMATED